UNITY Biotechnology to Participate in Upcoming September Investor Conferences
SAN FRANCISCO, Sept. 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that members of its senior management team will participate in the following upcoming September investor conferences:
Citi 15th Annual BioPharma Virtual Conference
Date: September 9, 2020
Location: Virtual – 1x1 only
Morgan Stanley 18th Annual Global Healthcare Conference
Date: September 15, 2020
Fireside Chat Time: 4:15 PM E.T.
Location: Virtual
Cantor Fitzgerald Virtual Healthcare Conference Conference
Date: September 16, 2020
Presentation Time: 10:00 AM E.T.
Location: Virtual
A live audio webcast of the fireside chat and presentation from the Morgan Stanley and Cantor Fitzgerald conferences will be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following each event.
About UNITY
UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY's initial focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related diseases, such as osteoarthritis, eye diseases, neurological diseases and pulmonary diseases. More information is available at or follow us on .
Investors Endurance Advisors Mike Zanoni Media Canale Communications Jason Spark
